Luciferase News and Research

RSS
S-pseudotyped VLPs offer promising COVID-19 vaccine platform

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

SARS-CoV-2 hijacks antiviral factors to promote infection in human lung cells

SARS-CoV-2 hijacks antiviral factors to promote infection in human lung cells

Majority of recovered COVID-19 patients have low neutralizing antibody titers

Majority of recovered COVID-19 patients have low neutralizing antibody titers

Promega introduces new serological antibody test for COVID-19

Promega introduces new serological antibody test for COVID-19

Bioluminescent molecule in fireflies shines light on mitochondrial activity

Bioluminescent molecule in fireflies shines light on mitochondrial activity

Study: Drinking honeysuckle decoction accelerates the negative conversion of COVID-19 patients

Study: Drinking honeysuckle decoction accelerates the negative conversion of COVID-19 patients

Stabilized prefusion spike vaccine candidate induces powerful immune response

Stabilized prefusion spike vaccine candidate induces powerful immune response

New test rapidly determines neutralizing antibodies against Sars-Cov-2

New test rapidly determines neutralizing antibodies against Sars-Cov-2

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

Cat catches coronavirus from owners

Cat catches coronavirus from owners

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Research shows how SARS-CoV-2 alters translation

Research shows how SARS-CoV-2 alters translation

A biomaterial vaccine for SARS-CoV-2 - quick and scalable

A biomaterial vaccine for SARS-CoV-2 - quick and scalable

New assay rapidly tests SARS-CoV-2 neutralization and screens antivirals

New assay rapidly tests SARS-CoV-2 neutralization and screens antivirals

Interesting study on which species may be infected by SARS-CoV-2

Interesting study on which species may be infected by SARS-CoV-2

Mutational targets of SARS-CoV-2 receptor-binding domain for vaccine-antiviral development

Mutational targets of SARS-CoV-2 receptor-binding domain for vaccine-antiviral development

Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

New information on viral antigens could improve COVID-19 testing

New information on viral antigens could improve COVID-19 testing

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.